Current Portfolio
Merus
Innovative full-length bispecific and trispecific antibody therapeutics for oncology.
Key Facts
- Sector
Life Sciences
- Country
Netherlands
- Fund
LSP 4
- Entry
2010
Website
Do You Want to Know More?
We are eager to explore how we can achieve great things together.